M300 is a first-in-class antibody program designed to conditionally induce the formation of Tertiary Lymphoid Structures (TLS) in the tumor. TLSs are aggregates of immune cells that form in tumor ...

A recent Nature Immunology study explores the cellular and molecular adaptations associated with human secondary lymphoid tissue in adults during viral infection. Lymphoid tissues play a vital role in ...

New Haven, Conn. — The National Institutes of Health (NIH) has awarded a grant to fund cellular senescence research in lymphoid organs at Yale Cancer Center. The five-year, $6.5 million grant will ...

Scientists at the Pasteur Institute in France say they have developed artificial lymphoid organ-chips that recreate much of the human immune system’s response to booster vaccines. The technology, ...